Cargando…
ISAR‐PEBIS (Paclitaxel‐Eluting Balloon Versus Conventional Balloon Angioplasty for In‐Stent Restenosis of Superficial Femoral Artery): A Randomized Trial
BACKGROUND: Paclitaxel‐eluting balloon (PEB) angioplasty has superior efficacy compared with conventional balloon angioplasty (BA) for de novo lesions of superficial femoral artery (SFA). Studies investigating the angiographic and clinical performance of PEB angioplasty versus BA for in‐stent resten...
Autores principales: | Ott, Ilka, Cassese, Salvatore, Groha, Philipp, Steppich, Birgit, Voll, Felix, Hadamitzky, Martin, Ibrahim, Tareq, Kufner, Sebastian, Dewitz, Karl, Wittmann, Theresa, Kasel, Albert Markus, Laugwitz, Karl‐Ludwig, Schunkert, Heribert, Kastrati, Adnan, Fusaro, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586321/ https://www.ncbi.nlm.nih.gov/pubmed/28743787 http://dx.doi.org/10.1161/JAHA.117.006321 |
Ejemplares similares
-
Effect of Erythropoietin in patients with acute myocardial infarction: five-year results of the REVIVAL-3 trial
por: Steppich, Birgit, et al.
Publicado: (2017) -
Aortic Valve Predilatation with a Small Balloon, without Rapid Pacing, prior to Transfemoral Transcatheter Aortic Valve Replacement
por: Shivaraju, Anupama, et al.
Publicado: (2018) -
Ten-year clinical outcomes of polymer-free versus durable polymer new-generation drug-eluting stent in patients with coronary artery disease with and without diabetes mellitus: Results of the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol- and Zotarolimus-Eluting Stents (ISAR-TEST 5) trial
por: Koch, Tobias, et al.
Publicado: (2021) -
High on-aspirin treatment platelet reactivity and restenosis after percutaneous coronary intervention: results of the Intracoronary Stenting and Antithrombotic Regimen-ASpirin and Platelet Inhibition (ISAR-ASPI) Registry
por: Mayer, Katharina, et al.
Publicado: (2023) -
Ten‐Year Clinical Outcomes of Biodegradable Versus Durable Polymer New‐Generation Drug‐Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus
por: Lenz, Tobias, et al.
Publicado: (2021)